FdaApplication
ANDA 207226
Identifiers
- fda_app_no: ANDA207226
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2018-07-27 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEUCOVORIN CALCIUM | LEUCOVORIN CALCIUM | EQ 500MG BASE/50ML (EQ 10MG BASE/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS |
1 product